Skip to main content
. 2007 Aug 6;51(10):3642–3649. doi: 10.1128/AAC.00160-07

FIG. 1.

FIG. 1.

(A and B) CFU counts indicating the total populations of PAO1 cells and the populations of mutant cells during treatment with meropenem (three 1-g doses) (A) and during treatment with ceftazidime (three 2-g doses) (B). (C) CFU counts indicating the total population of 12-09-15 cells and the population of mutant cells during treatment with meropenem (three 1-g doses). Arrows indicate dosing times.